| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Centre de Recherche en Infectiologie, Centre Hospitalier de l’Université Laval, Centre Hospitalier Universitaire de Québec, and Faculté de Médecine, Département de Biologie Médicale, Université Laval, Sainte-Foy, Québec, Canada
It is now well established that the HIV type 1 (HIV-1) incorporates a vast array of host-encoded molecules in its envelope during the budding process. Interestingly, it was demonstrated that the attachment process is accentuated by supplementary interactions between virion-anchored host molecules and their cognate ligands. Such an enhancement of the viral attachment process was found to result in an increase of infectivity for both T and macrophage-tropic strains of HIV-1. Given that previous work indicates that HIV-1 is budding at the site of cell-to-cell contact, a location rich in the costimulatory CD28 glycoprotein, we investigated whether CD28 could be efficiently acquired by HIV-1. We have been able to generate progeny viruses bearing or not bearing on their surfaces host-derived CD28 using our previously described transient transfection and expression system. The physical presence of CD28 was found to markedly increase virus infectivity in a CD28/B7-dependent manner following infection of two human lymphoid cell lines expressing high levels of surface B7-1/B7-2, two natural ligands of CD28. The physiological significance of CD28 incorporation was provided by the observation that an anti-CD28 Ab decreased replication in primary human mononuclear cells of clinical isolates of HIV-1 propagated in such cells. A virus precipitation assay revealed that M-, T-, and dual-tropic clinical strains of HIV-1 produced in primary human mononuclear cells do indeed incorporate CD28. These results show for the first time that HIV-1 can incorporate CD28 and the acquisition of this specific host surface glycoprotein modulates the virus life cycle.
This article has been cited by other articles:
|
|
 |
|
  S. M. Wahl, T. Greenwell-Wild, and N. Vazquez HIV accomplices and adversaries in macrophage infection J. Leukoc. Biol., November 1, 2006; 80(5): 973 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kolegraff, P. Bostik, and A. A. Ansari Characterization and role of lentivirus-associated host proteins. Experimental Biology and Medicine, March 1, 2006; 231(3): 252 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Holm and D. Gabuzda Distinct Mechanisms of CD4+ and CD8+ T-Cell Activation and Bystander Apoptosis Induced by Human Immunodeficiency Virus Type 1 Virions J. Virol., May 15, 2005; 79(10): 6299 - 6311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Roy, G. Martin, J.-F. Giguere, D. Belanger, M. Petrin, and M. J. Tremblay HIV Type 1 Can Act as an APC upon Acquisition from the Host Cell of Peptide-Loaded HLA-DR and CD86 Molecules J. Immunol., April 15, 2005; 174(8): 4779 - 4788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Giguere, S. Bounou, J.-S. Paquette, J. Madrenas, and M. J. Tremblay Insertion of Host-Derived Costimulatory Molecules CD80 (B7.1) and CD86 (B7.2) into Human Immunodeficiency Virus Type 1 Affects the Virus Life Cycle J. Virol., June 15, 2004; 78(12): 6222 - 6232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Callahan, P. M. Popernack, S. Tsutsui, L. Truong, R. A. Schlegel, and A. J. Henderson Phosphatidylserine on HIV Envelope Is a Cofactor for Infection of Monocytic Cells J. Immunol., May 1, 2003; 170(9): 4840 - 4845. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
